<html>
<head>
<title>ISH and Calcium Channel Blocker</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<script language="JavaScript">
<!--
function MM_goToURL() { //v3.0
  var i, args=MM_goToURL.arguments; document.MM_returnValue = false;
  for (i=0; i<(args.length-1); i+=2) eval(args[i]+".location='"+args[i+1]+"'");
}
//-->
</script>
</head>

<body bgcolor="#EBFBFE" text="#000000">
<div align="center"></div>
<ul>
  <li><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="660033">Isolated 
    systolic hypertension and wide pulse pressure in elderly persons increase 
    the risk for mortality and morbidity, treatment reduces this risk. (<a href="#" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/ISH%20and%20CCB_content.html#Staessen2000');return document.MM_returnValue">Staessen 
    2000</a>) </font></li>
  <li><font face="Verdana, Arial, Helvetica, sans-serif" size="-1" color="660033">Nitrendipine(DHP) 
    compared to placebo reduced risk of fatal and non fatal stroke by 42% in two 
    years, but not all cause mortality, in patients with isolated systolic hypertension. 
    (<a href="file:///E|/VA/Tabs/Original%20papers/Calcium%20Channel%20Blocker%20and%20ISH_OP.html#Staessen" onClick="MM_goToURL('parent.frames[\'main_banner\']','file:///E|/VA/Tabs/Banners/PubMed.htm','parent.frames[\'main_content\']','file:///E|/VA/Tabs/Original%20papers/ISH%20and%20CCB_content.html#Staessen');return document.MM_returnValue">Staessen 
    1997</a>)</font></li>
  <li><font face="Verdana, Arial, Helvetica, sans-serif" size="-1" color="660033">Although 
    nitrendipine is not available in the USA, dihydropyridine calcium channel 
    blockers (felodipine or nifedipine) are recommended as an alternative to thiazides 
    in first line therapy of isolated systolic hypertension.</font></li>
</ul>
<p><font color="660066" face="Verdana, Arial, Helvetica, sans-serif" size="2">Table 
  1: <b>Outcomes of a randomized controlled trial of nitrendipine vs placebo in 
  patients with ISH</b></font></p>
<table width="100%" border="1" cellspacing="0">
  <tr bgcolor="#FEE0E9"> 
    <td bordercolor="#000000" width="9%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" size="2" color="660066">Study</font></b></td>
    <td bordercolor="#000000" width="10%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" size="2" color="660066"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">Type 
      of study</font></font></b></td>
    <td bordercolor="#000000" width="8%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" size="2" color="660066">Patients</font></b></td>
    <td bordercolor="#000000" width="17%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" size="2" color="660066">Intervention</font></b></td>
    <td bordercolor="#000000" width="8%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" color="660066" size="2">Follow 
      up</font></b></td>
    <td bordercolor="#000000" width="21%" rowspan="2"><b><font color="660066" face="Arial, Helvetica, sans-serif" size="2">Outcomes</font> 
      </b> 
      <div align="center"></div>
    </td>
    <td bordercolor="#000000" colspan="2"><font face="Arial, Helvetica, sans-serif" size="2" color="660066"><b>Event 
      rate</b></font></td>
    <td bordercolor="#000000" width="11%" rowspan="2"><b><font face="Arial, Helvetica, sans-serif" color="660066" size="2">Relative 
      Risk Reduction</font></b></td>
  </tr>
  <tr bgcolor="#FEE0E9"> 
    <td bordercolor="#000000" width="8%"><font size="2" face="Arial, Helvetica, sans-serif" color="660066">Placebo</font></td>
    <td bordercolor="#000000" width="8%"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">Active</font></td>
  </tr>
  <tr bgcolor="#FEE0E9"> 
    <td bordercolor="#000000" rowspan="3" width="9%"><font face="Arial, Helvetica, sans-serif" size="2" color="660066"><a href="file:///E|/VA/Tabs/Original%20papers/Calcium%20Channel%20Blocker%20and%20ISH_OP.html#Staessen">Staessen 
      1997</a> </font></td>
    <td bordercolor="#000000" rowspan="3" width="10%"><font face="Arial, Helvetica, sans-serif" size="2" color="660066"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">double 
      blind randomized controlled trial </font></font></td>
    <td bordercolor="#000000" rowspan="3" width="8%"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">4695 
      patients, mean age 70 yrs, 66% women, mean SBP 173, mean DBP 87</font></td>
    <td bordercolor="#000000" rowspan="3" width="17%"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">Nitrendipine 
      (step up with enalapril and hydrochlorothiazide) vs. matching placebos</font></td>
    <td bordercolor="#000000" rowspan="3" width="8%"><font face="Arial, Helvetica, sans-serif" color="660066" size="2">2 
      yrs</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2">&nbsp;</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2">&nbsp;</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2">&nbsp;</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2">&nbsp;</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2">&nbsp;</font><font face="Arial, Helvetica, sans-serif" color="660066" size="2"> 
      (median) </font></td>
    <td bordercolor="#000000" width="21%"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">Stroke(fatal 
      and non fatal endpoints combined)</font> <font color="660066" face="Arial, Helvetica, sans-serif" size="2"><b>a</b></font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">77/2297 
      (3.4%) </font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">47/2398 
      (2%)</font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="11%"> 
      <div align="center"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">42%</font></div>
    </td>
  </tr>
  <tr bgcolor="#FEE0E9"> 
    <td bordercolor="#000000" width="21%"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">Cardiac 
      endpoints(fatal and non fatal endpoints combined)</font> <font color="660066" face="Arial, Helvetica, sans-serif" size="2"><b>b</b></font><b><font color="660066" face="Arial, Helvetica, sans-serif" size="2">,c</font></b><font color="660066" face="Arial, Helvetica, sans-serif" size="2"><br>
      </font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">114/2297 
      (5%) </font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">89/2398 
      (3.7%) </font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="11%"> 
      <div align="center"><font color="660066" face="Arial, Helvetica, sans-serif" size="2"><i>ns</i></font></div>
    </td>
  </tr>
  <tr bgcolor="#FEE0E9"> 
    <td bordercolor="#000000" width="21%"><font color="660066" face="Arial, Helvetica, sans-serif" size="2">All-cause 
      mortality <b>c</b></font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">137/2297 
      (6%)</font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="8%" align="center"><font face="Arial, Helvetica, sans-serif" size="2" color="660066">123/2398 
      (5.1%) </font></td>
    <td bordercolor="#000000" bgcolor="#FECFDD" width="11%"> 
      <div align="center"><i><font color="660066" face="Arial, Helvetica, sans-serif" size="2">ns</font></i></div>
    </td>
  </tr>
  <tr bgcolor="#FEE0E9"> 
    <td colspan="9"><font face="Arial, Helvetica, sans-serif" size="2" color="660066"><i><b>ns</b></i> 
      not significant;<b> a</b> primary endpoint; <b>b</b> includes fatal and 
      non fatal heart failure, fatal and non fatal myocardial infarction and sudden 
      death; <b>c</b> secondary endpoints</font></td>
  </tr>
</table>
</body>
</html>
